Evoq Remedies share price
BSE: 543500Commercial Services & SuppliesSmall Cap
Last close ₹1.86down ₹0.09 (4.62%)
Share price at the BSE close on 22 Oct 2026. Previous close ₹1.95.
52-week range of traded prices to 22 Oct 2026
₹1.35Low, 22 Sep 2026₹6.11High, 24 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4.63 Cr4,812th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 May 2026
- −0.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 16,000
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 30 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.00 Crdown 100.00%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.29 CrHalf year to Sep 2025: ₹0.05 Cr
Revenue by year
Peak revenue ₹26 Cr, year to Mar 2026
Net profit by year, a loss in red
- Net profit
- Loss
A loss in the year to Mar 2026, −₹0.24 CrA loss in 1 of the 5 years shown
| ₹ crore | Sep 2022Filed 21 Nov | Mar 2023Filed 26 May | Sep 2023Filed 29 Nov | Mar 2024Filed 25 Jun | Sep 2024Filed 4 Mar | Mar 2025Filed 10 Apr | Sep 2025Filed 10 Oct | Mar 2026Filed 30 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.8 | 4.6 | 3.9 | 0.1 | 0.0 | 11.8 | 25.5 | 0.0 |
| Net profit | 0.3 | 1.3 | 0.1 | 0.4 | −1.6 | 1.7 | 0.1 | −0.3 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 1.9% | 28.6% | 1.3% | 260.2% | – | 14.6% | 0.2% | – |
Standalone. The last eight half years. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Trading of Agro Commodity, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −10.2% | – | – | 0.0% |
| 3 years | −43.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Trading & Distributors, 196 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Evoq Remedies in market cap. Evoq Remedies's own figures are from its last trade, on 22 Oct 2026. 3 companies in the table last traded before then: their rows are priced on their last trade.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 IGC IndustriesIGCIL | 5 | – | 4.3 | – | – | – | −105.3% | −1,846.7% | 0.00% |
 Ambitious PlastomacAMBIT | 5 | 32.3 | – | 30.3 | +70.2% | +99.6% | – | 49.8% | 0.00% |
 Thakkers GroupTHAKKERS | 5 | – | 0.1 | 11.7 | +109.1% | −115.2% | −2.2% | 0.0% | 0.00% |
 Modella WoollensMODWOOL | 5 | – | – | – | – | – | – | – | 0.00% |
 Saianand CommercialSAICOM | 5 | – | 0.1 | – | −96.7% | – | – | −0.8% | 0.00% |
 PriyaPRIYALT | 4 | 1.0 | – | – | – | – | – | – | 0.00% |
 Jainco Projects (India)JAINCO | 4 | 653.8 | 0.4 | 21.1 | −43.2% | −87.1% | 0.1% | 2.4% | 0.00% |
| Revati MediaREVAMEDIA | 4 | – | 7.0 | – | – | – | −43.3% | −11.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Jun 2026
11 Jun · Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
10 Jun · Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
May 2026
Evoq Remedies share price by year
Each calendar year to 2025.Evoq Remedies share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 3.19 | −59.1% | 8.18 | 2.18 |
| 2024 | 7.80 | −47.1% | 16.90 | 7.31 |
| 2023 | 14.75 | +3.9% | 16.50 | 11.30 |
| 2022 | 14.20 | – | 23.75 | 11.27 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 30 Mar 2022.
Recent sessions
The last 10 trading days to 22 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 22 Oct 2026 | 1.94 | 1.94 | 1.86 | 1.86 | 1.88 | 16,000 |
| 19 Oct 2026 | 1.97 | 1.97 | 1.93 | 1.95 | 1.95 | 28,000 |
| 16 Oct 2026 | 1.84 | 1.89 | 1.84 | 1.88 | 1.89 | 84,000 |
| 15 Oct 2026 | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 | 4,000 |
| 14 Oct 2026 | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 | 8,000 |
| 13 Oct 2026 | 1.64 | 1.72 | 1.64 | 1.72 | 1.68 | 8,000 |
| 12 Oct 2026 | 1.60 | 1.64 | 1.60 | 1.64 | 1.61 | 20,000 |
| 9 Oct 2026 | 1.64 | 1.64 | 1.64 | 1.64 | 1.64 | 28,000 |
| 8 Oct 2026 | 1.55 | 1.64 | 1.55 | 1.64 | 1.59 | 8,000 |
| 7 Oct 2026 | 1.55 | 1.59 | 1.54 | 1.59 | 1.56 | 12,000 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 21 Feb 2025 | Price move | – | Between two trading sessions the price moved by a fifth or more. The company made an announcement in time for trading that day or the trading day before. Not adjusted for. |
Each event is noted and not adjusted for.
Company details
- Legal name
- Evoq Remedies Limited
- BSE code
- 543500
- ISIN
- INE0JVD01011
- Industry
- Commercial Services & Supplies
- Listed
- Mar 2022
- Face value
- ₹10
- CIN
- L46209GJ2010PLC059692
- Corporate identity number, the registrar of companies' code for it